Alfred Lin
Partner @ Sequoia Capital
Menlo Park, United States
Alfred Lin is a seed investor at Sequoia Capital in Menlo Park focused on Software and Artificial Intelligence. Alfred Lin is based out of San Francisco, California and is the Managing Partner of Sequoia Capital. Alfred Lin attended Stanford University.
- Total investments:
- 113
- Last investment:
- Lead investor:
- 44%
Last updated:
For AI agents: llms.txt
Industries Alfred Lin invests in
Stages Alfred Lin invests in
Countries Alfred Lin invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 14 (12%)
- Artificial Intelligence 14 (12%)
- E-Commerce 8 (7%)
- Internet 7 (6%)
- Health Care 7 (6%)
Stage
- Seed 22 (19%)
- Series A 19 (17%)
- Series B 18 (16%)
- Series C 12 (11%)
- Series D 10 (9%)
Country
- United States 54 (48%)
- Israel 1 (1%)
- Bahamas 1 (1%)
- Germany 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Abby Care focuses on supporting families by helping caregivers receive compensation through Medicaid for caring for children with disabilities or special needs. The organization aims to place families at the center of its operations, providing resources and guidance to navigate Medicaid processes. Abby Care also offers information on ABA therapyand other supportive services to assist parents and caregivers in enhancing the care they provide. | $82M / Series C / Oct 15, 2026 | ||
| Our mission at HealthLeap is to improve global health through better nutrition. We're addressing one of the most significant contributors to global deaths by building a clinical assistant to help healthcare professionals better treat/prevent disease-related malnutrition — the "silent killer" that worsens health outcomes fornearly all sick patients. It is associated with a 3-5x increase in mortality during a hospital stay and affects 30-50% of all hospital patients, but only 5% are diagnosed. | $8M / Seed / Oct 07, 2026 | ||
| HealthLeap provides an AI-driven clinical decision support platform for hospital teams. The platform analyzes electronic health record data to surface adult inpatients who may be at nutritional risk and highlights contributing factors. It supports registered dietitians by prioritizing assessments and identifying patients who might otherwise be missed. HealthLeap focuses on malnutrition screening today and develops additional modules for conditions such as congestive heart failure readmissions, pressure injuries, and food insecurity. It integrates into existing clinical workflows while leaving final decisions with clinicians. | $8M / Seed / Oct 07, 2026 | ||
Profound
|
FatherSonMatchingShirts store offers a wide variety of apparel such as t-shirts, sweatshirts, hoodies, tank tops, and mugs. We're trying our best to bring customers. You are welcome to FatherSonMatchingShirts. We're trying our best to bring customers the shirts are made of high quality materials for maximum comfort in whatever you do. | $180M / Series D / Sep 15, 2026 | |
| Clay provides a platform for go-to-market teams to use unique data and AI. The platform offers access to over 100 data providers for contact information, firmographics, and other data points. It also includes an AI research agent to automate manual research and create flexible workflows. | $115M / Series D / Sep 09, 2026 | ||
| AI agents for modern health systems | $25M / Series B / Jul 16, 2026 | ||
| Anthropic develops artificial intelligence tools and research initiatives focused on creating AI systems and models for business and research use. The company produces the Claude family of AI products, including conversational and coding assistants, integrations with productivity applications, and developer APIs that organizations can deploy for automation, information retrieval, and task workflows. It also engages in systematic research and analysis of AI behavior, safety methods, and policy issues to inform product design and external stakeholders. Beyond product development, Anthropic generates documented insights and collaborates with academic, civil society, and industry groups to explore implications of AI on economic and societal systems. These efforts aim to connect foundational research with practical AI applications in enterprise environments. | $50B / Series H / May 28, 2026 | ||
| Turnkey is an encryption service provider that offers secure APIs to manage private keys. | $12.5M / Venture - Series Unknown / May 14, 2026 | ||
| Nominal is the faster, more reliable way to validate mission-critical systems. We build workflows for the modern hardware team. | $80M / Series B / Mar 05, 2026 | ||
| Rowspace provides an AI platform for financial institutions to make decisions using proprietary data. The platform focuses on organizing, processing, and analyzing internal datasets alongside market information. It applies artificial intelligence and machine learning techniques tailored to financial workflows. Rowspace supports use cases such asinvestment research, risk analysis, and product strategy. The company works with financial services firms that want to operationalize data for day-to-day and strategic decisions. | $50M / Series A / Feb 25, 2026 | ||
| See all 113 investments → | |||
Co-Investors
About Sequoia Capital
Sequoia Capital provides capital alongside strategic guidance, supporting areas such as product development, company building, and market expansion. The firm engages with a limited number of companies at a time, working closely with leadership teams throughout the business lifecycle. Sequoia Capital focuses on long-term partnerships, often entering at the idea or formation stage and remaining involved as companies scale and mature. Its approach emphasizes collaboration among its internal team and portfolio founders, drawing on shared experience to address operational and strategic challenges.
Sequoia Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anas Biad
Partner
|
|||
Andrew Lee
Vice President
|
|||
Carl Eschenbach
Partner
|
|||
Caroline Fu
Vice President
|
|||
Donald Valentine
Founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Alfred Lin invest in?
Alfred Lin invests primarily in Software, Artificial Intelligence and E-Commerce startups, most often at Seed and Series A stage. Most of the 113 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alfred Lin?
Public channels for Alfred Lin include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Alfred Lin last invest?
The most recent investment recorded for Alfred Lin closed in Oct 2026. Shizune tracks 113 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
